| – Total net sales of |
| – Net income of |
| – EBITDA of |
| – Confirms full-year Outlook - |
| – Board of Directors approves |
“Against a still uncertain economic backdrop, our first quarter results show that we are continuing to move
First Quarter Results
For the first quarter ended
First Quarter 2026 Dividend
The Board of Directors declared a quarterly dividend of
2026 Full-Year Outlook
The Company continues to forecast full-year 2026 net sales in the range of
Webcast and Conference Call
The Company will host a webcast and conference call at
Disclosure Regarding Forward Looking Statements
Certain matters discussed in this press release are “forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified by use of the words “may,” “will,” “should,” “could,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” “project,” “potential,” or “plan” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements in this press release may include, without limitation: (1) projections of revenue, income, and other items relating to our financial position and results of operations, including short term and long term plans for cash, (2) statements of our plans, objectives, strategies, goals and intentions, (3) statements regarding the capabilities, capacities, market position and expected development of our business operations and (4) statements of expected industry and general economic trends.
Such forward-looking statements are subject to certain risks and uncertainties that may materially adversely affect the anticipated results. Such risks and uncertainties include, but are not limited to, the following: the impact of competition; uncertainties related to tariffs, duties, trade wars and related matters, supply disruptions, inflationary environments (including with respect to shipping costs and the cost of finished goods and raw materials and shipping costs), employment levels (including labor shortages), and general economic and political conditions in the areas of the world in which the Company operates or from which it sources its supplies or the areas of
About
Established in 1920,
Investor Relations Contact:
Investors@Superiorgroupofcompanies.com
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (In thousands, except shares and per share data) | ||||||||
| Three Months Ended | ||||||||
| 2026 | 2025 | |||||||
| Net sales | $ | 140,878 | $ | 137,097 | ||||
| Costs and expenses: | ||||||||
| Cost of goods sold | 88,544 | 86,656 | ||||||
| Selling and administrative expenses | 50,368 | 50,102 | ||||||
| Interest expense, net | 912 | 1,245 | ||||||
| 139,824 | 138,003 | |||||||
| Income (loss) before income tax expense (benefit) | 1,054 | (906 | ) | |||||
| Income tax expense (benefit) | 220 | (148 | ) | |||||
| Net income (loss) | $ | 834 | $ | (758 | ) | |||
| Net income (loss) per share: | ||||||||
| Basic | $ | 0.06 | $ | (0.05 | ) | |||
| Diluted | $ | 0.06 | $ | (0.05 | ) | |||
| Weighted average shares outstanding during the period: | ||||||||
| Basic | 14,629,019 | 15,599,655 | ||||||
| Diluted | 14,917,845 | 15,599,655 | ||||||
| Cash dividends per common share | $ | 0.14 | $ | 0.14 | ||||
CONSOLIDATED BALANCE SHEETS (In thousands, except shares and par value data) | ||||||||
| 2026 | 2025 | |||||||
| (Unaudited) | ||||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 23,172 | $ | 23,691 | ||||
| Accounts receivable, net | 84,917 | 104,336 | ||||||
| Inventories | 97,430 | 97,474 | ||||||
| Contract assets | 55,313 | 48,903 | ||||||
| Prepaid expenses and other current assets | 13,903 | 13,259 | ||||||
| Total current assets | 274,735 | 287,663 | ||||||
| Property, plant and equipment, net | 35,966 | 37,352 | ||||||
| Operating lease right-of-use assets | 12,157 | 12,620 | ||||||
| Deferred tax asset | 14,987 | 15,003 | ||||||
| Intangible assets, net | 46,359 | 47,254 | ||||||
| 2,583 | 2,583 | |||||||
| Other assets | 19,734 | 19,369 | ||||||
| Total assets | $ | 406,521 | $ | 421,844 | ||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 45,159 | $ | 48,343 | ||||
| Other current liabilities | 48,324 | 53,041 | ||||||
| Current portion of long-term debt | 7,031 | 6,563 | ||||||
| Total current liabilities | 100,514 | 107,947 | ||||||
| Long-term debt | 80,279 | 87,093 | ||||||
| Long-term pension liability | 15,123 | 15,010 | ||||||
| Long-term acquisition-related contingent liabilities | 919 | 826 | ||||||
| Long-term operating lease liabilities | 7,586 | 7,939 | ||||||
| Other long-term liabilities | 9,349 | 10,211 | ||||||
| Total liabilities | 213,770 | 229,026 | ||||||
| Shareholders’ equity: | ||||||||
| Preferred stock, | - | - | ||||||
| Common stock, | 16 | 16 | ||||||
| Additional paid-in capital | 84,857 | 84,628 | ||||||
| Retained earnings | 111,233 | 112,871 | ||||||
| Accumulated other comprehensive loss, net of tax: | (3,355 | ) | (4,697 | ) | ||||
| Total shareholders’ equity | 192,751 | 192,818 | ||||||
| Total liabilities and shareholders’ equity | $ | 406,521 | $ | 421,844 | ||||
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (In thousands) | ||||||||
| Three Months Ended | ||||||||
| 2026 | 2025 | |||||||
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net income (loss) | $ | 834 | $ | (758 | ) | |||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | ||||||||
| Depreciation and amortization | 2,858 | 3,204 | ||||||
| Inventory write-downs | 1,095 | 441 | ||||||
| Credit loss expense | 314 | 131 | ||||||
| Share-based compensation expense | 887 | 1,283 | ||||||
| Change in fair value of acquisition-related contingent liabilities | 93 | 287 | ||||||
| Non-cash operating lease expense | 1,019 | 900 | ||||||
| Other, net | 46 | 86 | ||||||
| Changes in assets and liabilities: | ||||||||
| Accounts receivable | 19,415 | 2,607 | ||||||
| Contract assets | (6,397 | ) | 1,069 | |||||
| Inventories | (994 | ) | (2,191 | ) | ||||
| Prepaid expenses and other current assets | 159 | 749 | ||||||
| Other assets | (391 | ) | 113 | |||||
| Accounts payable and other current liabilities | (9,044 | ) | (9,262 | ) | ||||
| Other long-term liabilities | (537 | ) | (647 | ) | ||||
| Net cash provided by (used in) operating activities | 9,357 | (1,988 | ) | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Additions to property, plant and equipment | (568 | ) | (1,131 | ) | ||||
| Net cash used in investing activities | (568 | ) | (1,131 | ) | ||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Borrowings under revolving lines of credit | 10,000 | 19,000 | ||||||
| Payments under revolving lines of credit | (15,000 | ) | (8,000 | ) | ||||
| Payments of term loan | (1,406 | ) | (1,406 | ) | ||||
| Payments of cash dividends | (2,164 | ) | (2,280 | ) | ||||
| Shares withheld for taxes net of proceeds received on exercise of stock options | (288 | ) | 87 | |||||
| Common shares repurchased and retired | (678 | ) | (3,777 | ) | ||||
| Net cash (used in) provided by financing activities | (9,536 | ) | 3,624 | |||||
| Effect of currency exchange rates on cash | 228 | 486 | ||||||
| Net decreases in cash and cash equivalents | (519 | ) | 991 | |||||
| Cash and cash equivalents balance, beginning of period | 23,691 | 18,766 | ||||||
| Cash and cash equivalents balance, end of period | $ | 23,172 | $ | 19,757 | ||||
NON-GAAP FINANCIAL MEASURES (Unaudited) (In thousands) | ||||||||
| Three Months Ended | ||||||||
| 2026 | 2025 | |||||||
| Net income (loss) | $ | 834 | $ | (758 | ) | |||
| Interest expense, net | 912 | 1,245 | ||||||
| Income tax expense (benefit) | 220 | (148 | ) | |||||
| Depreciation and amortization | 2,858 | 3,204 | ||||||
| EBITDA(1) | $ | 4,824 | $ | 3,543 | ||||
| EBITDA margin(1) | 3.4 | % | 2.6 | % | ||||
(1) EBITDA, which is a non-GAAP financial measure, is defined as net income excluding interest expense, net, income tax expense and depreciation and amortization expense. EBITDA margin is defined as EBITDA divided by net sales. The Company believes EBITDA is an important measure of operating performance because it allows management, investors and others to evaluate and compare the Company’s core operating results from period to period by removing (i) the impact of the Company’s capital structure (interest expense from outstanding debt), (ii) tax consequences and (iii) asset base (depreciation and amortization). The Company uses EBITDA internally to monitor operating results and to evaluate the performance of its business. In addition, the compensation committee has used EBITDA in evaluating certain components of executive compensation, including performance-based annual incentive programs. EBITDA is not a measure of financial performance under GAAP. EBITDA should not be considered in isolation or as an alternative to net income, cash flows from operating activities or any other measure determined in accordance with GAAP. The items excluded to calculate EBITDA are significant components in understanding and assessing the Company’s results of operations. The Company’s EBITDA may not be comparable to a similarly titled measure of another company because other entities may not calculate EBITDA in the same manner.
SUPPLEMENTAL INFORMATION - REPORTABLE SEGMENTS (Unaudited) (In thousands) | ||||||||||||||||||||||||
| Branded Products | Healthcare Apparel | Contact Centers | Intersegment Eliminations | Other | Total | |||||||||||||||||||
| For the Three Months Ended | ||||||||||||||||||||||||
| Net sales | $ | 90,869 | $ | 28,601 | $ | 22,253 | $ | (845 | ) | $ | - | $ | 140,878 | |||||||||||
| Cost of goods sold | 59,882 | 18,420 | 10,639 | (397 | ) | - | 88,544 | |||||||||||||||||
| Gross margin | 30,987 | 10,181 | 11,614 | (448 | ) | - | 52,334 | |||||||||||||||||
| Selling and administrative expenses | 24,746 | 10,778 | 9,563 | (448 | ) | 5,729 | 50,368 | |||||||||||||||||
| Depreciation and amortization | 1,374 | 823 | 588 | - | 73 | 2,858 | ||||||||||||||||||
| Segment EBITDA(1) | $ | 7,615 | $ | 226 | $ | 2,639 | $ | - | $ | (5,656 | ) | $ | 4,824 | |||||||||||
| Branded Products | Healthcare Apparel | Contact Centers | Intersegment Eliminations | Other | Total | |||||||||||||||||||
| For the Three Months Ended | ||||||||||||||||||||||||
| Net sales | $ | 86,474 | $ | 27,263 | $ | 24,225 | $ | (865 | ) | $ | - | $ | 137,097 | |||||||||||
| Cost of goods sold | 58,787 | 17,130 | 11,244 | (505 | ) | - | 86,656 | |||||||||||||||||
| Gross margin | 27,687 | 10,133 | 12,981 | (360 | ) | - | 50,441 | |||||||||||||||||
| Selling and administrative expenses | 23,420 | 9,526 | 10,921 | (360 | ) | 6,595 | 50,102 | |||||||||||||||||
| Depreciation and amortization | 1,480 | 912 | 722 | - | 90 | 3,204 | ||||||||||||||||||
| Segment EBITDA(1) | $ | 5,747 | $ | 1,519 | $ | 2,782 | $ | - | $ | (6,505 | ) | $ | 3,543 | |||||||||||
(1) Segment EBITDA is our primary measure of segment profitability under
Source: 